A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study

BACKGROUND: To evaluate activity and tolerability of two anthracycline-containing regimens as first-line treatment for anthracycline-naïve relapsed breast cancer patients. METHODS: Patients with relapsed breast cancer not previously treated with adjuvant anthracyclines were randomly assigned to epir...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Vici, Patrizia, Colucci, Giuseppe, Giotta, Francesco, Sergi, Domenico, Filippelli, Gianfranco, Perri, Pasquale, Botti, Claudio, Vizza, Enrico, Carpino, Armando, Pizzuti, Laura, Latorre, Agnese, Giannarelli, Diana, Lopez, Massimo, Di Lauro, Luigi
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2011
الموضوعات:
Research
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082232/
https://ncbi.nlm.nih.gov/pubmed/21481280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-30-39
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة